NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,353,077 | -15.3% | 30,578 | -6.9% | 0.01% | -12.5% |
| Q2 2023 | $1,597,654 | -12.4% | 32,833 | 0.0% | 0.02% | -11.1% |
| Q1 2023 | $1,822,888 | +38.2% | 32,833 | 0.0% | 0.02% | +50.0% |
| Q4 2022 | $1,318,902 | -1.5% | 32,833 | +7.4% | 0.01% | +20.0% |
| Q3 2022 | $1,339,000 | -34.0% | 30,561 | -46.6% | 0.01% | -33.3% |
| Q2 2022 | $2,029,000 | -41.1% | 57,262 | -32.3% | 0.02% | -25.0% |
| Q1 2022 | $3,443,000 | -52.5% | 84,641 | +9.0% | 0.02% | -55.6% |
| Q4 2021 | $7,250,000 | +91.9% | 77,628 | +129.0% | 0.04% | +36.4% |
| Q3 2021 | $3,778,000 | – | 33,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |